Fred Alger Management, LLC Quidel Ortho Corp Transaction History

Fred Alger Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$58.16 - $75.44 $4.51 Million - $5.86 Million	-77,628 Reduced 58.12%	55,943 $4.12 Million
Q3 2023 Nov 14, 2023	SELL	$70.9 - $88.63 $42.6 Million - $53.3 Million	-601,326 Reduced 81.82%	133,571 $9.76 Million
Q2 2023 Aug 14, 2023	SELL	$81.09 - $94.16 $9.73 Million - $11.3 Million	-119,946 Reduced 14.03%	734,897 $60.9 Million
Q1 2023 May 15, 2023	SELL	$82.98 - $91.46 $23.3 Million - $25.7 Million	-281,017 Reduced 24.74%	854,843 $76.2 Million
Q4 2022 Feb 14, 2023	SELL	$66.93 - $97.5 $4.68 Million - $6.82 Million	-69,910 Reduced 5.8%	1,135,860 $97.3 Million
Q3 2022 Nov 14, 2022	BUY	$69.86 - $107.63 $70,209 - $108,168	1,005 Added 0.08%	1,205,770 $86.2 Million
Q2 2022 Aug 15, 2022	BUY	$89.06 - $117.64 $107 Million - $142 Million	1,204,765 New	1,204,765 $117 Million

293

67.9M

337K

134K

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.74B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.